Open: 111.95 Close: 111.04 Change: -0.91

Today's Summary

Abbott Laboratories is one of the biggest players in the baby formula space. Abbott is betting on the cancer diagnostics market, expanding its footprint there.the lawsuits allege that Abbott failed to provide warnings about the risks of its products, was negligent, and misrepresented the safety of the products. at the heart of the cases is the question of whether Abbotts specialized formulas caused the babies to contract NEC, a disease in which tissue lining the intestine becomes inflamed and dies. the lawsuit resulted in a $495 million verdict against Abbott in 2024.